Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2012.200 | A Phase 2, Randomized Study to Evaluate the Efficacy and Safety of MEDI-546 in Subjects with Systemic Lupus Erythematosus | Prof. TAM Lai Shan |
| 2012.007 | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BIIB023 in Subjects With Lupus Nephritis | Prof. TAM Lai Shan |
| 2012.559 | A randomized, double-blind, parallel, placebo-controlled study assessing the efficacy and safety of sarilumab added to non-biologic DMARD therapy in patients with rheumatoid arthritis who are inadequate responders to or intolerant of TNF-α antagonists | Prof. TAM Lai Shan |
| 2008.344 | Premature Atherosclerosis in Early Rheumatoid Arthritis | Prof Tam Lai Shan |
| 2008.391 | A Multi-Center, Continuation Trial of Belimumab (HGS1006, LymphoStat-B™), A Fully Human Monoclonal Anti-BLyS Antibody, in Subjects with Systemic Lupus Erythematosus (SLE) who Completed the Phase 3 Protocol HGS1006-C1056 or HGS1006-C1057 | Prof. TAM Lai Shan |
| 2020.530 | 5-Year Cardiovascular Event Risk in Early Rheumatoid Arthritis Patients who received Treat-to-Target Management: a population-based cohort study |
Prof. TAM Lai Shan 譚麗珊 |
| 2019.573 | Subclinical gut inflammation and gut microbiome in axial spondyloarthritis patients in Hong Kong |
Prof. TAM Lai Shan 譚麗珊 |
| 2019.264 | Incidence of and associated factors of infective complications in rheumatology patients taking DMARDs | Dr. TAM Lai Shan |
| 2019.650 | Effects of tight-control strategy with and without rosuvastatin on progression of subclinical coronary and carotid atherosclerosis in psoriatic arthritis- a randomized placebo-controlled study |
Prof. TAM Lai Shan 譚麗珊 |
| 2019.540 | A PHASE 2B, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY PROFILE OF PF-06700841 IN PARTICIPANTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS (SLE). |
Dr. TAM Lai Shan 譚麗珊 |
| 2018.225 | The APLAR Spondyloarthritis (SpA) Registry |
Prof. TAM Lai Shan 譚麗珊 |
| 2020.141 | Quantification of erosion, joint space width and new bone formation using deep learning-based approaches |
Prof. TAM Lai Shan 譚麗珊 |
| 2019.063 | Effects of tight-control strategy with rosuvastatin on progression of subclinical carotid and coronary atherosclerosis in psoriatic arthritis- a prospective cohort study |
Prof. TAM Lai Shan 譚麗珊 |
| 2019.247 | Survival benefit of statin use in patients with immune mediated inflammatory diseases in Hong Kong - A population-based study | Prof. TAM Lai Shan |
| 2018.144 | Bone Microarchitecture Assessed by 3D High-resolution Peripheral Quantitative Computed Tomography (HR-pQCT) as predictor of fracture risk in patients with glucocorticoid-induced osteoporosis |
Prof. TAM Lai Shan 譚麗珊 |
| 2019.401 | Immunological role of the ILC2-B lymphocyte regulatory axis in systemic lupus erythematosus |
Prof. TAM Lai Shan 譚麗珊 |
| 2020.617 | Subclinical atherosclerosis in axial spondyloarthritis- a cross-sectional study |
Prof. TAM Lai Shan 譚麗珊 |
| 2019.224 | Effects of achieving SDAI remission on joint space outcomes progression in early rheumatoid arthritis: an HR-pQCT study |
Prof. TAM Lai Shan 譚麗珊 |
| 2020.128 | Portable integrated diagnostic platform for chronic auto-immune diseases |
Prof. TAM Lai Shan 譚麗珊 |
| 2020.519 | Cardiovascular events in axial spondyloarthritis |
Prof. TAM Lai Shan 譚麗珊 |
| 2020.129 | Vascular effects of achieving low disease activity in axial spondyloarthritis - a 2-year prospective cohort study |
Prof. TAM Lai Shan 譚麗珊 |
| 2020.704 | Bone Erosion Volume Assessed by 3D High-resolution Peripheral Quantitative Computed Tomography (HR-pQCT) as predictor of disability in patients with rheumatoid arthritis | Prof. TAM Lai Shan |
| 2019.180 | The microbiome study in psoriasis and psoriatic arthropathy patients in Hong Kong |
Prof. TAM Lai Shan 譚麗珊 |
| 2018.417 | Prevention of metacarpophalangeal joints structure damage in patients with psoriatic arthritis using tofacitinib | Prof. TAM Lai Shan |
| 2020.516 | CUHK Rheumatology Research Centre Imaging Database of Rheumatic Diseases |
Prof. TAM Lai Shan 譚麗珊 |
| 2023.181 | Anti-inflammatory mechanisms of immune-adipose-related Meteorin-like protein (METRNL) in Systemic Lupus Erythematosus | Dr. TAM Lai Shan |
| 2021.401 | A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase III Study Evaluating the Efficacy and Safety of Anifrolumab in Asian Participants with Active Systemic Lupus Erythematosus |
Dr. TAM Lai Shan 譚麗珊 |
| 2021.187 | A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Dapirolizumab pegol in Study Participants with Moderately to Severely Active Systemic Lupus Erythematosus |
Prof. TAM Lai Shan 譚麗珊 教授 |
| 2021.460 | Profiling of Serum Protein Biomarkers in Psoriatic Arthritis–Associated Disease Activity Assessment and Bone Damage |
Prof. TAM Lai Shan 譚麗珊 |
| 2022.151 | Osteosarcopenia Assessed by 3D High-resolution Peripheral Quantitative Computed Tomography (HR-pQCT) and fracture risk in non-osteoporotic patients with immune-mediated inflammatory disease |
Prof. TAM Lai Shan 譚麗珊 |
| 2021.315 | Axial involvement in patients with Psoriatic Arthritis in Hong Kong – a cross-sectional pilot study |
Prof TAM Lai Shan 譚麗珊 |
| 2023.189 | Survey of cardiovascular disease Risk Factors in Psoriatic Arthritis | Prof. TAM Lai Shan |
| 2023.633 | Defining active and structural lesions in the sacroiliac joint and spine by MRI and their predictive utility in axial psoriatic arthritis -a prospective study | Prof Tam Lai Shan |
| 2023.355 | Sex- And Gender-based analysis of the Effectiveness of advanced therapies in Psoriatic Arthritis | Prof. TAM Lai Shan |
| 2023.127 | Machine learning models to quantify and predict radiographic joint damage in rheumatoid arthritis |
Prof. TAM Lai Shan Lai Shan TAM |
| 2022.686 | Bone Erosion Volume Assessed by 3D High-resolution Peripheral Quantitative Computed Tomography (HR-pQCT) as predictor of disability in patients with psoriatic arthritis | Prof. TAM Lai Shan |
| 2023.051 | Discovering new post-translational modification patterns for the early diagnosis of rheumatoid arthritis | Prof. TAM Lai Shan |
| 2021.343 | AXIAL INVOLVEMENT IN PSORIATIC ARTHRITIS COHORT (AXIS) a joint ASAS-GRAPPA project |
Prof. TAM Lai Shan 譚麗珊 |
| 2021.706 | Effect of Achieving Minimal Disease on the Progression of Subclinical Coronary Atherosclerosis: A Citywide Prospective Cohort Study in Psoriatic Arthritis |
Prof. TAM Lai Shan 譚麗珊 |
| 2021.568 | A Phase 4, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Bio-naive Participants with Active Psoriatic Arthritis Axial Disease |
Prof. TAM Lai Shan 譚麗珊 |
| 2023.306 | Low-dose computed tomography for the detection of structural changes in axial psoriatic arthritis | Prof. TAM Lai Shan |
| 2023.317 | Early identification of axial psoriatic arthritis among patients with psoriasis: a screening study using low-dose computed tomography | Prof. TAM Lai Shan |
| 2024.352 | A Phase 3 Randomized, Double-blind, Multi-center, Placebo-controlled Study to Evaluate the Efficacy and Safety of AR882 in Participants with Gout |
Prof. TAM Lai Shan 譚麗珊 |
| 2024.182 | Causal machine learning models for prediction of serious infection events in inflammatory arthritis: a population-based study |
Prof Tam Lai Shan Lai Shan TAM |
| 2024.193 | Lowest Efficacious Dose in Psoriatic Arthritis (LED PsA): A Multicentre Non-inferiority Randomized Open-Label Controlled Trial Assessing b/tsDMARDs Spacing | Prof. TAM Lai Shan |
| 2024.221 | Evaluation of molecular and cellular dysregulation in systemic lupus erythematosus |
Prof. TAM Lai Shan 譚麗珊 |
| 2015.065 | Phase 3b/4 Randomized Safety Endpoint Study Of 2 Doses Of Tofacitinib In Comparison To A Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis | Prof. TAM Lai Shan |
| 2017.146 | Circulating microRNAs as biomarkers for predicting the early development, repair and progression of bone erosions in early rheumatoid arthritis using HR-pQCT |
Prof. TAM Lai Shan 譚麗珊 |
| 2015.697 | Freely circulating microRNAs as biomarkers for fracture and bone loss in female patients with systemic lupus erythematosus on long-term glucocorticoid therapy |
Prof. TAM Lai Shan 譚麗珊 |
| 2015.334 | Characterization of the potential role of interleukin-36 (IL-36) in regulating protective and pathogenic B cells in systemic lupus erythematosus |
Dr. TAM Lai Shan 譚麗珊 |
Page 60 of 254.